The Japanese Journal of Pharmacology · 1983 · 27 citations · 27 references
MedicinePharmacologyPharmacotherapyExperimental PharmacologyGeneral PharmacologyPharmacodynamicsCardiovascular PharmacodynamicsCardiovascular PharmacologyHemodynamic PharmacologyVasoactive Drug TherapyVasoactive MedicationsVeterinary NeuropharmacologyCardiovascular Drug PharmacologyPharmacodynamics Of Cardiovascular DrugsVeterinary Pharmacodynamics
The effects of flurazepam and diazepam, benzodiazepine derivatives, on contractions (or contractures) induced by Ca++, K+ or norepinephrine were examined in the isolated canine coronary artery and thoracic aorta. Ca++-Induced contraction was evoked by cumulative addition of CaCl2 to Ca++-depleted K+-depolarizing solution; K+: and norepinephrine-induced contractions were evoked by cumulative addition of KCl and norepinephrine, respectively, to the medium. Flurazepam and diazepam (1 X 10(-5), 3 X 10(-5) and 1 X 10(-4) M for coronary artery; 3 X 10(-5) and 1 X 10(-4) M for thoracic aorta) shifted the dose-response curves for KCl downwards in a non-competitive manner, and shifted the dose-response curves for CaCl2 to the right in a competitive manner. Ca++-Induced contracture was inhibited completely by addition of flurazepam or diazepam (1 X 10(-4) M), and the inhibition was reversed dose-dependently by addition of CaCl2. Flurazepam and diazepam (3 X 10(-5) and 1 X 10(-4) M) shifted the dose-response curves for norepinephrine both rightwards and downwards in the thoracic aorta. These findings suggest that flurazepam and diazepam inhibit Ca++-influx into the cells (Ca++-antagonistic effect), causing relaxation and inhibition of K+-, Ca++-, or norepinephrine-induced contraction (or contracture) of the vascular smooth muscle.
27
Mollie E. Holman · The Journal of Physiology · 1958 · 185 citations
Hisashi Hidaka, Miki Asano, Shuichi Iwadare et al. · Journal of Pharmacology and Experimental Therapeutics · 1978 · 171 citations